Current Neuro-Oncology

Volume 22 Number 10
31 May 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 10, 31 May

Jangra A, Choi SA, Yang J, Koh EJ, Phi JH, Lee JY, Wang KC, Kim SK.
Disulfiram potentiates the anticancer effect of cisplatin in atypical teratoid/rhabdoid tumors (AT/RT).
Cancer Lett. 2020 May 16, 2020;486:38-45∟. doi: 10.1016/j.canlet.2020.05.006∟. PMID: 32428661∟. Laboratory investigation. ˍ

Sabour S.
Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy; Methodological issues to avoid misinterpretation.
Magn Reson Imaging. 2020 May 16, 2020;71:25-26∟. doi: 10.1016/j.mri.2020.05.005∟. PMID: 32428548∟. Comment. ˍ
Refers to: Larsson C, et al.,Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
Magn Reson Imaging. 2020 Jan 28, 2020;68:106-112∟. doi: 10.1016/j.mri.2020.01.012∟. PMID: 32004711∟. Observational study. ˍ

Zhang L, Yu H, Xue Y, Liu Y.
Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
Childs Nerv Syst. 2020 May 16, 2020;36(7):1345-1346∟. doi: 10.1007/s00381-020-04665-9∟. PMID: 32418048∟. Case report. ˍ

Wu F, Li GZ, Liu HJ, Zhao Z, Chai RC, Liu YQ, Jiang HY, Zhai Y, Feng YM, Li RP, Zhang W.
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
J Pathol. 2020 May 17, 2020;251(3):272-283∟. doi: 10.1002/path.5468∟. PMID: 32418210∟. Observational study. ˍ

Miyake JA, Gomes RN, Colquhoun A.
Gamma-linolenic acid alters migration, proliferation and apoptosis in human and rat glioblastoma cells.
Prostaglandins Other Lipid Mediat. 2020 May 18, 2020;150:106452∟. doi: 10.1016/j.prostaglandins.2020.106452∟. PMID: 32439412∟. Laboratory investigation. ˍ

Rodrigues LF, Camacho AHDS, Spohr TCLSE.
Secondary glioblastoma metastasis outside the central nervous system in a young HIV-infected patient.
Ther Adv Med Oncol. 2020 May 18, 2020;12:1758835920923432∟. doi: 10.1177/1758835920923432∟. PMID: 32489434∟. Case report. ˍ

Stragliotto G, Pantalone MR, Rahbar A, Bartek J, Söderberg-Nauclér C.
Valganciclovir as add-on to standard therapy in glioblastoma patients.
Clin Cancer Res. 2020 May 18, 2020;26(15):4031-4039∟. doi: 10.1158/1078-0432.CCR-20-0369∟. PMID: 32423968∟. Observational study. ˍ

Li Z, Wu H, Wu B, Lyu J, Liu Y, Tang C, Hua W, Hu S, Wang Y, Zhang Y.
Long term follow-up and outcomes in adult patients with thalamic gliomas.
Clin Neurol Neurosurg. 2020 May 19, 2020;195:105888∟. doi: 10.1016/j.clineuro.2020.105888∟. PMID: 32450499∟. Observational study. ˍ

Van Gool SW, Makalowski J, Bonner ER, Feyen O, Domogalla MP, Prix L, Schirrmacher V, Nazarian J, Stuecker W.
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience.
Medicines (Basel). 2020 May 19, 2020;7(5):E29∟. doi: 10.3390/medicines7050029∟. PMID: 32438648∟. Observational study. ˍ

Whitmire P, Rickertsen CR, Hawkins-Daarud A, Carrasco E Jr, Lorence J, De Leon G, Curtin L, Bayless S, Clark-Swanson K, Peeri NC, Corpuz C, Lewis-de Los Angeles CP, Bendok BR, Gonzalez-Cuyar L, Vora S, Mrugala MM, Hu LS, Wang L, Porter A, Kumthekar P, Johnston SK, Egan KM, Gatenby R, Canoll P, Rubin JB, Swanson KR.
Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients.
BMC Cancer. 2020 May 19, 2020;20(1):447∟. doi: 10.1186/s12885-020-06816-2∟. PMID: 32429869∟. Observational study. ˍ

Khayat Kashani HR, Azhari S, Nayebaghayee H, Salimi S, Mohammadi HR.
Prediction value of preoperative findings on meningioma grading using artificial neural network.
Clin Neurol Neurosurg. 2020 May 20, 2020;196:105947∟. doi: 10.1016/j.clineuro.2020.105947∟. PMID: 32521393∟. Observational study. ˍ

Mosaab A, El-Ayadi M, Khorshed EN, Amer N, Refaat A, El-Beltagy M, Hassan Z, Soror SH, Zaghloul MS, El-Naggar S.
Histone H3K27M Mutation Overrides Histological Grading in Pediatric Gliomas.
Sci Rep. 2020 May 20, 2020;10(1):8368∟. doi: 10.1038/s41598-020-65272-x∟. PMID: 32433577∟. Laboratory investigation. ˍ

Nobre L, Zapotocky M, Ramaswamy V, Ryall S, Bennett J, Alderete D, Balaguer Guill J, Baroni L, Bartels U, Bavle A, Bornhorst M, Boue DR, Canete A, Chintagumpala M, Coven SL, Cruz O, Dahiya S, Dirks P, Dunkel IJ, Eisenstat D, Faure Conter C, Finch E, Finlay JL, Frappaz D, Garre ML, Gauvain K, Bechensteen AG, Hansford JR, Harting I, Hauser P, Hazrati LN, Huang A, Injac SG, Iurilli V, Karajannis M, Kaur G, Kyncl M, Krskova L, Laperriere N, Larouche V, Lassaletta A, Leary S, Lin F, Mascelli S, McKeown T, Milde T, Morales La Madrid A, Morana G, Morse H, Mushtaq N, Osorio DS, Packer R, Pavelka Z, Quiroga-Cantero E, Rutka J, Sabel M, Salgado D, Solano P, Sterba J, Su J, Sumerauer D, Taylor MD, Toledano H, Tsang DS, Valente Fernandes M, van Landeghem F, van Tilburg CM, Wilson B, Witt O, Zamecnik J, Bouffet E, Hawkins C, Tabori U.
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
JCO Precis Oncol. 2020 May 20, 2020;4:PO.19.00298∟. doi: 10.1200/PO.19.00298∟. PMID: 32923898∟. Observational study. ˍ

Reardon DA, Desjardins A, Rixe O, Cloughesy T, Alekar S, Williams JH, Li R, Taylor CT, Lassman AB.
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma.
Invest New Drugs. 2020 May 20, 2020;38(6):1784-1795∟. doi: 10.1007/s10637-020-00950-1∟. PMID: 32436060∟. Interventional study. ˍ

Dono A, Wang E, Lopez-Rivera V, Ramesh AV, Tandon N, Ballester LY, Esquenazi Y.
Molecular characteristics and clinical features of multifocal glioblastoma.
J Neurooncol. 2020 May 21, 2020;148(2):389-397∟. doi: 10.1007/s11060-020-03539-z∟. PMID: 32440969∟. Observational study. ˍ

Muftuoglu Y, Liau LM.
Results From the CheckMate 143 Clinical Trial: Stalemate or New Game Strategy for Glioblastoma Immunotherapy?
JAMA Oncol. 2020 May 21, 2020;6(7):987-989∟. doi: 10.1001/jamaoncol.2020.0857∟. PMID: 32437542∟. Editorial. ˍ
Refers to: Reardon DA, et al.,Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
JAMA Oncol. 2020 May 21, 2020;6(7):1003-1010∟. doi: 10.1001/jamaoncol.2020.1024∟. PMID: 32437507∟. Interventional study. ˍ

Nagtegaal SHJ, David S, Snijders TJ, Philippens MEP, Leemans A, Verhoeff JJC.
Effect of radiation therapy on cerebral cortical thickness in glioma patients: Treatment-induced thinning of the healthy cortex.
Neurooncol Adv. 2020 May 21, 2020;2(1):vdaa060∟. doi: 10.1093/noajnl/vdaa060∟. PMID: 32642712∟. Observational study. ˍ

Reardon DA, Brandes AA, Omuro A, Mulholland P, Lim M, Wick A, Baehring J, Ahluwalia MS, Roth P, Bähr O, Phuphanich S, Sepulveda JM, De Souza P, Sahebjam S, Carleton M, Tatsuoka K, Taitt C, Zwirtes R, Sampson J, Weller M.
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
JAMA Oncol. 2020 May 21;6(7):1003-1010∟. doi: 10.1001/jamaoncol.2020.1024∟. PMID: 32437507∟. Interventional study. ˍ

Shen S, Feng S, Liu H, Jiang J, Yu X.
Associations of histological and molecular alterations with invasion of the corpus callosum in gliomas.
Acta Neurochir (Wien). 2020 May 21, 2020;162(7):1691-1699∟. doi: 10.1007/s00701-020-04376-9∟. PMID: 32440925∟. Observational study. ˍ

Talabaev M, Venegas K, Zabrodets G, Zmachinskaya V, Antonenko A, Naumenko D, Salauyeva H, Churyla N.
Result of awake surgery for pediatric eloquent brain area tumors: single-center experience.
Childs Nerv Syst. 2020 May 21, 2020;36(11):2667-2673∟. doi: 10.1007/s00381-020-04666-8∟. PMID: 32435891∟. Observational study. ˍ

Wang Z, Liu F, Liao W, Yu L, Hu Z, Li M, Xia H.
Curcumin suppress glioblastoma cell proliferation by p-AKT/mTOR pathway and increased the PTEN expression.
Arch Biochem Biophys. 2020 May 21, 2020;689:108412∟. doi: 10.1016/j.abb.2020.108412∟. PMID: 32445778∟. Laboratory investigation. ˍ

Bergman D, Modh A, Schultz L, Snyder J, Mikkelsen T, Shah M, Ryu S, Siddiqui MS, Walbert T.
Randomized prospective trial of fractionated stereotactic radiosurgery with chemotherapy versus chemotherapy alone for bevacizumab-resistant high-grade glioma.
J Neurooncol. 2020 May 22, 2020;148(2):353-361∟. doi: 10.1007/s11060-020-03526-4∟. PMID: 32444980∟. Interventional study. ˍ

Cai HQ, Liu AS, Zhang MJ, Liu HJ, Meng XL, Qian HP, Wan JH.
Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas.
Front Oncol. 2020 May 22, 2020;10:669∟. doi: 10.3389/fonc.2020.00669∟. PMID: 32528873∟. Laboratory investigation. ˍ

Mousavi SM, Shayanfar M, Rigi S, Mohammad-Shirazi M, Sharifi G, Esmaillzadeh A.
Adherence to the Mediterranean dietary pattern in relation to glioma: A case-control study.
Clin Nutr. 2020 May 21, 2021;40(1):313-319∟. doi: 10.1016/j.clnu.2020.05.022∟. PMID: 32507514∟. Observational study. ˍ

Mistry AM, Mummareddy N, CreveCoeur TS, Lillard JC, Vaughn BN, Gallant JN, Hale AT, Griffin N, Wellons JC, Limbrick DD, Klimo P, Naftel RP.
Association between supratentorial pediatric high-grade gliomas involved with the subventricular zone and decreased survival: a multi-institutional retrospective study.
J Neurosurg Pediatr. 2020 May 22, 2020;26(3):288-294∟. doi: 10.3171/2020.3.PEDS19593∟. PMID: 32442975∟. Observational study. ˍ

Ferrer P, Barbero P, Monedero G, Presti AL, Bejarano B, Penanes JR.
Primary central nervous system lymphoma and 5-aminolevulinic acid.
Surg Neurol Int. 2020 May 23, 2020;11:122∟. doi: 10.25259/SNI_185_2020∟. PMID: 32494397∟. Case report. ˍ

Frankel BM, Cachia D, Patel SJ, Das A.
Targeting Subventricular Zone Progenitor Cells with Intraventricular Liposomal Encapsulated Cytarabine in Patients with Secondary Glioblastoma : A Report of Two Cases.
SN Compr Clin Med. 2020 May 23, 2020;2(6):836-843∟. doi: 10.1007/s42399-020-00322-z∟. PMID: 32704621∟. Case report. ˍ

Ahn S, Han KD, Park YM, Bae JM, Kim SU, Jeun SS, Yang SH.
Cigarette Smoking Is Associated with Increased Risk of Malignant Gliomas: A Nationwide Population-Based Cohort Study.
Cancers (Basel). 2020 May 25, 2020;12(5):E1343∟. doi: 10.3390/cancers12051343∟. PMID: 32466105∟. Observational study. ˍ

Chu C, Davis CM, Lan X, Hienz RD, Jablonska A, Thomas AM, Velarde E, Li S, Janowski M, Kai M, Walczak P.
Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease.
Int J Radiat Oncol Biol Phys. 2020 May 25, 2020;108(3):745-757∟. doi: 10.1016/j.ijrobp.2020.05.027∟. PMID: 32470502∟. Laboratory investigation. ˍ

Oliveira D, Stegmayr C, Heinzel A, Ermert J, Neumaier B, Shah NJ, Mottaghy FM, Langen KJ, Willuweit A.
High uptake of ⁶⁸Ga-PSMA and ¹⁸F-DCFPyL in the peritumoral area of rat gliomas due to activated astrocytes.
EJNMMI Res. 2020 May 25, 2020;10(1):55∟. doi: 10.1186/s13550-020-00642-0∟. PMID: 32451793∟. Laboratory investigation. ˍ

Saha D, Rabkin SD, Martuza RL.
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma.
J Immunother Cancer. 2020 May 25, 2020;8(1):e000345∟. doi: 10.1136/jitc-2019-000345∟. PMID: 32457126∟. Laboratory investigation. ˍ

Smoll NR, Mathews JD, Scurrah KJ.
CT scans in childhood predict subsequent brain cancer: Finite mixture modelling can help separate reverse causation scans from those that may be causal.
Cancer Epidemiol. 2020 May 25, 2020;67:101732∟. doi: 10.1016/j.canep.2020.101732∟. PMID: 32464497∟. Observational study. ˍ

Miller AM, DeAngelis LM.
Reevaluation of the Frequent Use of PD-1 Checkpoint Inhibitors for Treatment of Glioblastoma.
JAMA. 2020 May 26;10.1001/jama.2020.5934∟. doi: 10.1001/jama.2020.5934∟. PMID: 32453825∟. Comment. ˍ
REFERS TO: Reardon DA, et al.,Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020 May 21;6(7):1003-1010∟. doi: 10.1001/jamaoncol.2020.1024∟. PMID: 32437507∟. Interventional study. ˍ

Nantavithya C, Paulino AC, Liao K, McGovern SL, Grosshans DR, McAleer MF, Woodhouse KD, Khatua S, Chintagumpala MM, Majd NK, Yeboa DN.
Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.
Pediatr Blood Cancer. 2020 May 26;67(8):e28373∟. doi: 10.1002/pbc.28373∟. PMID: 32453481∟. Observational study. ˍ

Nicolaides T, Nazemi KJ, Crawford J, Kilburn L, Minturn J, Gajjar A, Gauvain K, Leary S, Dhall G, Aboian M, Robinson G, Long-Boyle J, Wang H, Molinaro AM, Mueller S, Prados M.
Phase I study of vemurafenib in children with recurrent or progressive BRAF^V600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).
Oncotarget. 2020 May 26, 2020;11(21):1942-1952∟. doi: 10.18632/oncotarget.27600∟. PMID: 32523649∟. Interventional study. ˍ

Reichl B, Niederstaetter L, Boegl T, Neuditschko B, Bileck A, Gojo J, Buchberger W, Peyrl A, Gerner C.
Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid.
Cancers (Basel). 2020 May 26, 2020;12(6):E1350∟. doi: 10.3390/cancers12061350∟. PMID: 32466393∟. Laboratory investigation. ˍ

Liu Y, Hu G, Yu Y, Jiang Z, Yang K, Hu X, Li Z, Liu D, Zou Y, Liu H, Chen J.
Structural and Functional Reorganization Within Cognitive Control Network Associated With Protection of Executive Function in Patients With Unilateral Frontal Gliomas.
Front Oncol. 2020 May 27, 2020;10:794∟. doi: 10.3389/fonc.2020.00794∟. PMID: 32528887∟. Observational study. ˍ

*

Vora P, Venugopal C, Salim SK, Tatari N, Bakhshinyan D, Singh M, Seyfrid M, Upreti D, Rentas S, Wong N, Williams R, Qazi MA, Chokshi C, Ding A, Subapanditha M, Savage N, Mahendram S, Ford E, Adile AA, McKenna D, McFarlane N, Huynh V, Wylie RG, Pan J, Bramson J, Hope K, Moffat J, Singh S.
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.
Cell Stem Cell. 2020 May 27, 2020;26(6):832-844.e6∟. doi: 10.1016/j.stem.2020.04.008∟. PMID: 32464096∟. Laboratory investigation. ˍ

Wongthida P, Schuelke MR, Driscoll CB, Kottke T, Thompson JM, Tonne J, Stone C, Huff AL, Wetmore C, Davies JA, Parker AL, Evgin L, Vile RG.
Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors.
Neuro Oncol. 2020 May 27, 2020;22(12):1757-1770∟. doi: 10.1093/neuonc/noaa126∟. PMID: 32459315∟. Laboratory investigation. ˍ

Alhoulaiby S, Abdulrahman A, Alouni G, Mahfoud M, Shihabi Z.
Extra-CNS metastasis of glioblastoma multiforme to cervical lymph nodes and parotid gland: A case report.
Clin Case Rep. 2020 May 28, 2020;8(9):1672-1677∟. doi: 10.1002/ccr3.2985∟. PMID: 32983474∟. Case report. ˍ

Brendle C, Klose U, Hempel JM, Schittenhelm J, Skardelly M, Tabatabai G, Ernemann U, Bender B.
Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.
Neurol Sci. 2020 May 28, 2020;41(12):3625-3632∟. doi: 10.1007/s10072-020-04474-7∟. PMID: 32462389∟. Observational study. ˍ

Lu VM, Brown DA, Daniels DJ.
Rare Diffuse Intrinsic Pontine Glioma Metastasis Throughout the Brain and Spine.
World Neurosurg. 2020 May 28, 2020;140:301-302∟. doi: 10.1016/j.wneu.2020.05.205∟. PMID: 32474088∟. Case report. ˍ

Madan R, Kumar N, Gupta A, Gupta K, Salunke P, Khosla D, Yadav BS, Kapoor R.
Effect of prophylactic granulocyte-colony stimulating factor (G-CSF) on acute hematological toxicity in medulloblastoma patients during craniospinal irradiation (CSI).
Clin Neurol Neurosurg. 2020 May 28, 2020;196:105975∟. doi: 10.1016/j.clineuro.2020.105975∟. PMID: 32505868∟. Observational study. ˍ

*

De Barros A, Attal J, Roques M, Nicolau J, Sol JC, Charni S, Cohen-Jonathan-Moyal E, Roux FE.
Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.
Clin Neurol Neurosurg. 2020 May 29, 2020;196:105972∟. doi: 10.1016/j.clineuro.2020.105972∟. PMID: 32512407∟. Observational study. ˍ

Rijnen SJM, Butterbrod E, Rutten GM, Sitskoorn MM, Gehring K.
Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
Neurosurgery. 2020 May 29, 2020;87(6):1119-1129∟. doi: 10.1093/neuros/nyaa190∟. PMID: 32470985∟. Observational study. ˍ

Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Meyer RE, Canfield MA, Rasmussen SA, Chambers TM, Spector LG, Plon SE, Lupo PJ.
Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases.
Cancer. 2020 May 29, 2020;126(15):3483-3492∟. doi: 10.1002/cncr.32982∟. PMID: 32469081∟. Observational study. ˍ

Takamori S, Seto T, Jinnouchi M, Matsubara T, Haratake N, Miura N, Toyozawa R, Yamaguchi M, Takenoyama M.
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancer.
Thorac Cancer. 2020 May 29, 2020;11(7):2056-2058∟. doi: 10.1111/1759-7714.13494∟. PMID: 32469140∟. Case report. ˍ

Zaragori T, Ginet M, Marie PY, Roch V, Grignon R, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A.
Use of static and dynamic ¹⁸F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression.
EJNMMI Res. 2020 May 29, 2020;10(1):56∟. doi: 10.1186/s13550-020-00645-x∟. PMID: 32472232∟. Observational study. ˍ

Santoro C, Picariello S, Palladino F, Spennato P, Melis D, Roth J, Cirillo M, Quaglietta L, D'Amico A, Gaudino G, Meucci MC, Ferrara U, Constantini S, Perrotta S, Cinalli G.
Retrospective Multicentric Study on Non-Optic CNS Tumors in Children and Adolescents with Neurofibromatosis Type 1.
Cancers (Basel). 2020 May 31, 2020;12(6):E1426∟. doi: 10.3390/cancers12061426∟. PMID: 32486389∟. Observational study. ˍ